Diplomat announces second quarter results, to review strategic alternatives
Diplomat Pharmacy announced financial results for the quarter ended June 30, 2019. Revenue decreased 9% from $1.4 billion to $1.2 billion and gross profit decreased from $98.4 million to $72.7 million from the prior-year quarter. Adjusted EBITDA was $19.3 million compared to $42.